FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dextrose 25% Injection
Status: Currently in Shortage
»Date first posted: 09/27/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Hospira, Inc. (Revised 10/07/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/mL (25%); Ansyr Plastic Syringe (NDC 0409-1775-10) Next Delivery: December 2019; Estimated Recovery: March 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English